All Articles in: Plastic/Reconstructive

CE Mark for RTI Surgical’s Fortiva™ Porcine DermisMarch 12, 2014

Pretty much a year after having gained the FDA’s nod for its Fortiva Porcine Dermis Patch, RTI Surgical Inc. has received CE mark approval for the product and says it will begin distribution throughout Europe.

Posted in: , ,

Good Year for CryoLife with Growth Across BusinessesFebruary 24, 2014

Some outstanding sales figures from tissue sealant, hemostat, vascular and preservation services businesses underpin annual revenue growth of 7 percent.

Posted in: , , ,

Bioprinting Promises 3D Tissue Constructs with Multiple Cell Types and Blood Vessels

Researchers have developed intricately patterned 3D tissue constructs with multiple types of cells and tiny blood vessels. The work could provide tissues that are realistic enough to screen drugs for safety and effectiveness. Ultimately it offers the potential for reconstructive surgery.

Posted in: ,

European Varicose Vein Landscape all Lumps and Bumps Says New Study

Varicose Vein treatments typify the adoption of new technologies, factors such as economics, reimbursement and clinical resistance all playing their part in ensuring that the old ways, while in decline, will endure for a while yet.

Posted in: , ,

New CE Mark Sees World’s First Externally Scannable RFID Breast implantsFebruary 18, 2014

A range of silicone breast implants with integrated RFID technology has been CE Marked. This means key data about the implants can be easily retrieved with the sweep of a scanner, rather than resorting to hospital records in the event of a recall or other clinical need.

Posted in: ,

FDA Clears Light-Based Skin Treatment DeviceFebruary 12, 2014

This is the first time we’ve ventured out into the world of aesthetic treatments, with the news that the FDA has given its blessing to a device that exploits the benefits of different forms of light to effect hair removal.

Posted in: ,

Shire Takes the Pain and Offloads DERMAGRAFT®January 20, 2014

Global Pharma company Shire plc, is to sell what it calls its “Dermagraft assets” to Organogenesis Inc. for what could add up to $300 million, but for now looks like a $650 million loss.

Posted in: , , ,

British Breast Implant Maker Sizes Up French MarketNovember 28, 2013

A division of GC Aesthetics, Nagor is the only breast implant manufacturer based in Britain. And in a piece of elegant commercial symmetry it has just announced that it is now launching its range in France, no doubt hoping its quality message and reputation will score heavily in the aftermath of a certain other silicone breast manufacturer.

Posted in: ,

Final PMA Module Submitted for TissuGlu® Surgical AdhesiveNovember 21, 2013

Surgical Adhesive manufacturer Cohera Medical, Inc.® has submitted its fourth and final FDA PMA module that would ultimately see TissuGlu® indicated for reducing drainage following abdominoplasty procedures in the US.

Posted in: , ,

Future Looking Bright for Invuity® as Eigr™Illumination Technology Showcases at Anterior Hip Course and Novation ExpoOctober 4, 2013

It seems San Francisco’s Invuity, Inc., has hit on a rich vein of unmet need as its clever illuminated retractor systems featured heavily in the last two weeks at both an anterior hip arthroplasty course and an innovation technology showcase hosted by one of the big healthcare supply chain companies.

Posted in: , , , , ,

FDA Clears Syneron Medical’s New VelaShape® III Platform for Abdominal Circumferential Reduction…CE Mark Too!September 11, 2013

Aesthetic medical device company Syneron Medical Ltd., has announced FDA clearance and CE mark approval for VelaShape® III, the Company’s new non-invasive body shaping platform. This new platform is said to be effective for temporary reduction in circumference of the abdomen and is also used in a wide range of other body shaping applications such as cellulite treatments.

Posted in: ,

Potential for Excellagen in Repair of Prenatally Diagnosed Birth Defects Using Mesenchymal Stem CellsAugust 13, 2013

Cardium Therapeutics has reported on a research collaboration with researchers at Boston Children’s Hospital, to assess the medical utility of Excellagen® as a delivery scaffold to seed autologous mesenchymal fetal stem cells for ex-vivo engineering of tissue grafts for transplantation into infants to repair prenatally diagnosed birth defects.

Posted in: , ,

FDA Nod For MENTOR® MemoryShape™ Breast ImplantsJune 18, 2013

Aesthetic Breast expert Mentor Worldwide LLC, has announced the U.S. FDA approval of its MENTOR® MemoryShape™ Breast Implants, providing new options for women looking for a more natural shape and youthful feel from breast enhancement or reconstruction surgery.

Posted in: ,

RTI Biologics® Sees Launch And First Use Of Fortiva™ Porcine Dermis In HerniaJune 11, 2013

Implant company RTI Biologics Inc. has launched its Fortiva™ porcine dermis implant at the Abdominal Wall Reconstruction (AWR) Conference in Washington, D.C., June 6-8. RTI claims this implant positions it as the only provider with a comprehensive biologic solutions portfolio …

Posted in: , ,

UK Plastic Surgeons Jump On Swedish PIP Results

When Sweden’s device authority called for all PIPs to be removed last week their evidence was seized upon by UK plastic surgeons in the form of their specialty body, the British Association for Aesthetic Plastic Surgeons (BAAPS) which is now …

Posted in: ,

Trial Will Test SurgiMend® PRS Breast Cancer Reconstruction Claims

TEI Biosciences, Inc. has gained FDA Investigational Device Exemption (IDE) approval to initiate a human clinical trial to gain specific claims of clinical benefits from use of SurgiMend® PRS in breast reconstruction following mastectomy for breast cancer. Background The approved …

Posted in: , , ,

<< Previous Articles